Carlos Pipaón

1.2k citations
26 papers · 995 indexed · h-index 15
Topics
Nuclear Receptors and Signaling (6 papers)Estrogen and related hormone effects (5 papers)Cancer-related Molecular Pathways (5 papers)

In The Last Decade

Carlos Pipaón

24 papers receiving 979 citations

Peers

Carlos Pipaón
Comparison fields: 5 of 88
  • Molecular Biology 484
  • Immunology 362
  • Genetics 262
  • Oncology 112
  • Surgery 106
Replace Élaine Beaulieu with:
Élaine Beaulieu Australia
Yves Bourlet France
Erik A. Eklund Sweden
Jana L. Jackson United States
Anne Cornet Belgium
Rachid Tazi‐Ahnini United Kingdom
D M Blakeley Slovakia
Bongkun Choi South Korea
Thomas C. Brodnicki Australia
Gloria Esposito Italy
Carlos Pipaón relative to Élaine Beaulieu Australia Élaine Beaulieu's profile →
Citations per field
00.5×4.1×
Élaine Beaulieu · 1×
Citations per year

Countries citing papers authored by Carlos Pipaón

Since Specialization
Citations

This map shows the geographic impact of Carlos Pipaón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Pipaón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Pipaón more than expected).

Fields of papers citing papers by Carlos Pipaón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Pipaón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Pipaón. The network helps show where Carlos Pipaón may publish in the future.

Co-authorship network of co-authors of Carlos Pipaón

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Pipaón. A scholar is included among the top collaborators of Carlos Pipaón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Pipaón. Carlos Pipaón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 5
4 3
5 1
6 30
7 29
8 62
9 31
10 21
11 15
12 17
13 7
14 88
15 355
16 6
17 98
18 14
19 56
20 67

About Carlos Pipaón

Carlos Pipaón is a scholar working on Genetics, Cancer Research and Cellular and Molecular Neuroscience, having authored 26 papers that have together received 995 indexed citations. Recurring topics across this work include Nuclear Receptors and Signaling (6 papers), Estrogen and related hormone effects (5 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Immunology (362 citations), Genetics (262 citations) and Molecular Biology (484 citations). Carlos Pipaón has collaborated with scholars based in Spain, United States and Switzerland. Frequent co-authors include José L. Fernández-Luna, Olga Gutiérrez, Ana Pérez‐Castillo, Ana Fontalba, Yasunori Ogura, Gabriel Núñez, Naohiro Inohara, Felipe Prósper, Ángel Santos and Sophia Y. Tsai. Their work appears in journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026